SCHEMBL767603

SCHEMBL767603

N#Cc1cc[c]c(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407722 0.74 TSHR (0.35)
SCHEMBL184366 0.73
SCHEMBL28407972 0.73
SCHEMBL407833 0.73
SCHEMBL9659680 0.73
SCHEMBL1357341 0.73
SCHEMBL289531 0.73
SCHEMBL351688 0.73
SCHEMBL1978737 0.72 APP (0.41)
SCHEMBL27984373 0.72 LOXL2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0031708-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR ICI PHARMA (FR) 1984-06-13 EP claimed
CN-110229109-A A kind of preparation method of 4- methylene quinazoline (sulphur) ketone compounds 台州学院 2019-09-13 CN disclosed
CN-106132962-B Macrocyclic compounds having an aromatic P2' group as factor XIA inhibitors 百时美施贵宝公司 2018-09-07 CN disclosed
CN-101568346-B HCV NS3 protease inhibitor MERCK SHARP & DOHME CORP. (US) 2015-11-25 CN disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
CN-103509030-A Camptothecin compound and preparation and application thereof LI YULIANG 2014-01-15 CN disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
US-20130245025-A1 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-09-19 US disclosed
CN-103313970-A Novel bicyclic compound or salt thereof TAIHO PHARMACEUTICAL CO LTD 2013-09-18 CN disclosed
EP-2619200-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2013-07-31 EP disclosed
US-20110136816-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-06-09 US disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-7906553-B2 Substituted thiophene modulators of intracellular calcium CALCIMEDICA, INC. (US) 2011-03-15 US disclosed
US-20100261725-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2010-10-14 US disclosed
CN-101568346-A Hcv ns3 protease inhibitors MERCK & CO INC (US) 2009-10-28 CN disclosed
EP-0138766-A2 Process for the preparation of substituted 1-phenyl indanes CIBA-GEIGY AG (CH) 1985-04-24 EP disclosed
US-4463173-A ANTIBIOTIC, BACTERICIDE ICI PHARMA (FR) 1984-07-31 US disclosed
EP-0031708-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR ICI PHARMA (FR) 1984-06-13 EP disclosed
EP-0031708-A2 Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor ICI PHARMA (FR) 1981-07-08 EP disclosed